Galapagos garners $9.7M milestone; FDA approves new Roche test for hep C drugs;

 @FierceBiotech: Popular yesterday: Theravance: Biotech's big coming-of-age story. Editor's Corner | Follow @FierceBiotech

@JohnCFierce: TauRx adds $10.5M to its unconventional trove of Alzheimer's PhIII cash. News | Follow @JohnCFierce

@RyanMFierce: Engineering issues have stymied the mini DNA sequencer from Oxford Bio. Blogger says the tech chief is angry: Report | Follow @RyanMFierce

> Galapagos says it earned a $9.7 million milestone from Servier for its alliances on osteoarthritis and oncology. Release

> The FDA has approved Roche's ($RHHBY) new viral load test to evaluate response to hepatitis C therapies. Release | More from FierceMedicalDevices

> Roche and BioLamina inked an R&D deal to jointly develop new cell culture systems for various applications, including stem cell research. Release

Pharma News

@FiercePharma: Longtime Roche chairman Franz Humer is stepping aside. Who's up next? More | Follow @FiercePharma

@EricPFierce: Pfizer building a plant in Saudi Arabia as MENA area becomes of more interest to Big Pharma. Story | Follow @EricPFierce

> FDA panel looks askance at calcitonin bone drugs. Report

> Lilly CEO blasts Europe's drug-pricing moves. Story

> Par to pay $45M for off-label Megace marketing. News

Medical Device News

 @FierceMedDev: Report: Life Tech may have found a buyer after all. Story | Follow @FierceMedDev

 @MarkHFierce: Royalty financing may not be new, but it's novel for the medical device world. More | Follow @MarkHFierce

 @DamianFierce: Boston Scientific is holding back some data on Watchman, and market watchers are a little spooked. Report | Follow @DamianFierce

> GI Dynamics revs up anti-obesity device for Brazilian market. Item

> Saladax secures $22.4M from Chinese pharma giant. Report

Biomarkers News

> Advanced Cell Diagnostics enables cancer immunotherapy biomarker work. Story

> Australian team builds depression blood test around quinolinic acid. More

> Biomarker shines a light on new pathway to target neuroblastoma. Report

> Scripps scientists spot tropical disease marker in urine. Article

> Ignyta, Lieden University team on RA biomarker research. Item

Drug Delivery News

@MichaelGFierce: Yale researchers improve lupus drug with nanogel delivery. More | Follow @MichaelGFierce

> Actium BioSystems puts the heat on cancer with hyperthermic delivery. Report

> Mercator micro-infusion drug delivery catheter snags CE mark. News

> Combo drug, Dx nanomedicine deliver cancer-fighting payload. Article

> West launches intradermal adapter for shallow injections. Item

And Finally… A team led by Rice physicist Ching-Hwa Kiang says that stresses in the flow of small blood vessels can change the shape of a common protein for up to 5 hours, significantly raising the risk of blood clots. The team will hunt for more information as it looks for new therapies to reduce the risk of blood clots. Release

 

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.